A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2009
11/26/2009	DE102004006048B4 Intravenös zu verabreichende Injektions-oder Infusionslösung enthaltend ein Kombinationsarzneimittel zur Verwendung als konstrastverstärkendes Mittel in der MR Angiographie Intravenous injection or infusion solution containing a combination drug for use as konstrastverstärkendes agent in MR angiography
11/26/2009	CA2724976A1 Novel ghrelin analogues
11/25/2009	EP2123677A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
11/25/2009	EP2121725A1 C-terminal attachment of two chemical groups to peptides
11/25/2009	EP2121042A2 Compounds and methods for detection of cells
11/25/2009	EP2121041A1 Visualization of biological material by the use of coated contrast agents
11/25/2009	EP2121040A1 Compositions containing metal oxide particles and their uses
11/25/2009	EP2121039A1 Nanoparticle clusters and methods for forming same
11/25/2009	EP2121038A2 Tantalum oxide nanoparticles as imaging agents for x-ray/computed tomography and methods for making same
11/25/2009	EP2121037A2 Imaging using radioactive monocations in combination with a receptor binding ligand that stimulates the influx of cations
11/25/2009	EP2121033A2 Color-marked oligosaccharides or polysaccharides
11/25/2009	EP2120722A1 Method of controlling a release of a material carried by ultrasound sensitive particles
11/25/2009	EP2120717A1 Pet visualization of amyloid-associated neuroinflammation in the brain
11/25/2009	EP2120697A1 Arrangement for magnetic particle imaging, method for influencing and/or detecting magnetic particles and magnetic particle
11/25/2009	EP1558595B1 Piperazinyl and diazapanyl benzamides and benzthioamides
11/25/2009	EP0754009B1 Magnetic resonance imaging using hyperpolarised noble gases
11/25/2009	CN101585868A Method for extracting natural colorant glycoprotein of eucheuma
11/24/2009	US7622306 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
11/24/2009	US7622128 Porphyromonas gingivalis 1435/1449 LPS as an immune modulator
11/24/2009	US7622114 Measuring the level of NR2A and/or NR2B NMDA receptor; for diagnosing stroke in an emergency room setting
11/24/2009	US7622113 Monoclonal antibodies that bind or neutralize dengue virus
11/24/2009	US7622101 Developmental animal model of temporal lobe epilepsy
11/24/2009	US7622100 Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
11/24/2009	CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009	CA2382651C Use of simple amino acids to form porous particles
11/24/2009	CA2164813C Stabilized microbubble compositions for ultrasound
11/19/2009	WO2009140510A1 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging
11/19/2009	WO2009140026A2 Renal function analysis method and apparatus
11/19/2009	WO2009139972A2 Site specific fluorescence marking and contrast marker for same
11/19/2009	WO2009139754A2 New reactions of fullerenes
11/19/2009	WO2009138499A2 Biomarkers for depression
11/19/2009	WO2009137964A1 Preparation of superparamagnetic composite microparticles from cyclodextrin
11/19/2009	WO2009108376A3 Contrast agents for applications including perfusion imaging
11/19/2009	WO2009077586A3 Methods and compositions for the preparation and use of toxin conjugates
11/19/2009	WO2009040843A3 Preparation of micro or nano systems detectable in biological environments based on inorganic oxides with controlled porosity for carrying biologically active or activable substances
11/19/2009	WO2006054240A3 Ultrasound contrast agents for molecular imaging
11/19/2009	US20090288181 Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
11/19/2009	US20090287078 Marker or filler forming fluid
11/19/2009	US20090287077 System for detecting function of intestinal barrier and method for using the same
11/19/2009	US20090286737 Erbb interface peptidomimetics and methods of use thereof
11/19/2009	US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009	US20090285843 Epitope sequences
11/19/2009	US20090285762 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging
11/19/2009	US20090285761 Renal Function Analysis Method and Apparatus
11/19/2009	US20090285760 Method for detecting cancer using icg fluorescence method
11/19/2009	US20090285758 In vivo system to monitor tissue responses in birds
11/19/2009	US20090285757 Methods of targeting cells for diagnosis and therapy
11/19/2009	US20090285754 Peptides for targeting apoptotic cells and uses thereof
11/19/2009	US20090285753 Novel haptotactic peptides
11/19/2009	DE102009021315A1 Prognostisches Verfahren Prognostic methods
11/19/2009	CA2727803A1 Metal abstraction peptide (map) tag and associated methods
11/19/2009	CA2721846A1 Renal function analysis method and apparatus
11/18/2009	EP2119457A1 Method of magnetic resonance investigation with hyperpolarised contrast agents
11/18/2009	EP2119456A1 Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe
11/18/2009	EP2117608A2 Magnetic resonance imaging
11/18/2009	EP2117607A1 Imaging agents and methods of use thereof
11/18/2009	EP2117606A1 Mri t1 contrasting agent comprising manganese oxide nanoparticle
11/18/2009	EP2117605A2 Imaging probes
11/18/2009	EP2117603A2 Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds
11/18/2009	EP2117600A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
11/18/2009	EP2117595A2 Remotely triggered release from heatable surfaces
11/18/2009	EP2117572A2 New fusion molecule based on novel taa variant
11/18/2009	EP2117505A2 Compositions and methods of their use for improving the condition and appearance of skin
11/18/2009	EP1501551B1 Folate-receptor targeted imaging agents
11/18/2009	EP1389240B1 Mdr1 variants and methods for their use
11/18/2009	CN101580850A Specificity expression marker gene on telomerase masculine tumor cell, slow virus for curing gene and application thereof
11/18/2009	CN100560138C NMR contrast agent and preparation method thereof
11/18/2009	CN100560131C Antibody targeting compounds
11/17/2009	US7619408 Spatially resolved determination of magnetic particle anisotropy in an area of examination
11/17/2009	US7618793 Screening agents for diminishing cellular toxicity associated with alpha-synuclein polypeptide of Parkinson's Disease; Huntington's Disease; inclusion bodies
11/17/2009	US7618615 Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
11/17/2009	US7618614 Intraventricular administration of hepatocyte growth factor (HGF)
11/17/2009	US7618567 Liquid permeable foam comprising radiopaque agent for use as tool in imaging biopsies and wokund puncture sites
11/17/2009	CA2383435C Implantable glucose sensor
11/17/2009	CA2304973C Stabilized preparations for use in nebulizers
11/17/2009	CA2157577C Growth differentiation factor-8
11/12/2009	WO2009137586A2 Use of inhaled substances for diagnosis of early lung cancer
11/12/2009	WO2009136764A2 Dual-modality pet/mri contrast agents
11/12/2009	WO2009136336A2 Medical microbubble generation
11/12/2009	WO2009136290A1 Functionalized pyrrolidines and use thereof as iap inhibitors
11/12/2009	WO2009136131A1 An agent for transporting nuclear spin order and for magnetic resonance imaging
11/12/2009	WO2009135937A2 Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging
11/12/2009	WO2009135778A1 Animal model for diabetes
11/12/2009	WO2009115967A3 Method for the synthesis of hollow spheres
11/12/2009	WO2009106551A3 Contrast agents
11/12/2009	WO2009038779A3 Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents
11/12/2009	US20090281287 IL-17 receptor like molecules and uses thereof
11/12/2009	US20090280503 Method for detecting and treating skin disorders
11/12/2009	US20090280064 Transdermal delivery of optical, spect, multimodal, drug or biological cargo laden nanoparticle(s) in small animals or humans
11/12/2009	US20090280063 Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging
11/12/2009	US20090280062 Longevity-promoting effects of acetic acid and reishi polysaccharide
11/12/2009	US20090280061 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
11/12/2009	US20090280060 Photochromic probes
11/12/2009	US20090280055 Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods
11/12/2009	CA2722829A1 Animal model for diabetes
11/11/2009	EP2116267A1 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for CEST applications
11/11/2009	EP2114905A1 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
11/11/2009	EP2114463A2 Ferrous oxide-binding peptides
11/11/2009	EP2114462A2 Compounds for fluorescence imaging
11/11/2009	EP2114461A2 Diagnostic and therapeutic cyclooxygenase-2 binding ligands

1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 354